相关实验视频

Updated: Jan 9, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

探索用于治疗耐火性肌痛性肌痛性肌痛症的西马布:单中心体验

Marija Roddate^1,2, Violeta Žukova¹, Arta Grosmane^1,2

¹Neurology, Paul Stradins Clinical University Hospital, Riga, Latvia.

BMJ neurology open

|December 10, 2025

概括

利图西马布在耐火性肌痛性肌痛症 (MG) 中表现有前途. 这种治疗改善了临床评分,并减少了难以治疗的MG患者的类固醇使用,没有显著的不良影响.

科学领域:

神经学神经学
免疫学免疫学免疫学
自免疫性疾病自免疫性疾病

背景情况:

骨髓灰质炎 (MG) 是一种自身免疫性疾病,影响神经肌肉传播,导致肌肉衰弱.
很大一部分MG患者 (约. 15%的患者对标准治疗不耐药,需要探索替代疗法.
作为一种免疫抑制剂的利图西马布正在研究其在治疗耐火性MG病例中的潜力.

研究的目的:

评估Rituximab在治疗不耐药的骨髓质疏松症患者的疗效和安全性.
评估利图西马布对临床结果和耐火性MG的皮质类固醇剂量的影响.
为促进对挑战自身免疫神经肌肉疾病的先进治疗策略的讨论做出贡献.

主要方法:

进行了一项前性队列研究,涉及9名耐火性MG患者.
患者接受了单次低剂量利图西马布,并被监测了6个月.
临床评估包括迷思重症综合评分 (MGCS),日常生活活动,生活质量评分和每日皮质类固醇剂量.

主要成果:

利图西马布治疗导致MGCS中位数显著下降,从11.5降至7.5 (p=0.025).
观察到日均皮质类固醇剂量显著减少,从15.0毫克降至8.5毫克 (p=0.036).
在研究期间没有报告MG恶化或重大不良反应.

结论:

利图西马布显示出作为耐火性肌痛性肌痛症的有效治疗选择的潜力.
该药物为治疗这种复杂的自身免疫性疾病提供了临床益处和有利的安全性.
进一步的研究是有必要的,以优化患者的选择和剂量策略,在耐火性MG里图西马布.

关键词:

迷思症 (Myasthenia) 是一种神经衰弱症.神经免疫学神经免疫学这是神经肌肉.药理学在药理学方面.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...